Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana

Recruiting now · Not applicable

Conditions studied: Cervical Cancer

In brief

Investigators will test the effectiveness of adaptive strategies on timely adoption of cervical cancer treatment in Botswana using a pragmatic trial design.

Key facts

Study ID

NCT05952141

Run by

Abramson Cancer Center at Penn Medicine

People needed

610

Starts

2023-09-01

Expected to finish

2027-08-31

Last updated by the study team

2026-07-22

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients will be eligible if they:
• are biological females
• are aged 18 or older
• have pathology-confirmed invasive cervical cancer diagnosis
• have pathology results evaluated at National Health Laboratory in Botswana
• are citizens of Botswana
• have no prior history of invasive cervical cancer

You may not qualify if…

• Patients will be excluded if they:
• are biological males or otherwise born without a cervix
• are below the age of 18 due to the rarity of cervical cancer in this population
• do not meet study inclusion criteria

Where it is running

• Nyangabgwe Referral Hospital — Francistown, North-East District, Botswana (enrolling)
• Princess Marina Hospital — Gaborone, Botswana (enrolling)
• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.